Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.

Date publication

août 2019

Journal

BMC psychiatry

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel

Tous les auteurs :
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, Alaïli N, Bellivier F, Bougerol T, Camus V, Dorey JM, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Llorca PM, Courtet P, Aouizerate B, Haffen E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31455302

Résumé

Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established.

Mots clés

Antidepressants, Expert consensus guidelines, Major depressive disorder, Pharmacotherapy, Treatment resistant depression

Référence

BMC Psychiatry. 2019 Aug 28;19(1):262